Emily Ames, Maggie Sanders, Marley Jacobs, and Thomas A. Vida (all Medicine) recently published a narrative review, "," delves into the significant challenges hidradenitis suppurativa (HS) poses. This debilitating chronic skin condition causes painful abscesses, recurrent nodules, and severe scarring in areas rich with apocrine glands, such as the groin and axillae. Patients with HS often endure profound physical pain, psychological distress, and social stigma, which can devastate their quality of life. Typically averaging over seven years, diagnostic delays exacerbate these issues, leaving many without timely intervention. Additionally, HS disproportionately affects specific populations, such as women in Europe and North America and Black Americans, who face heightened prevalence and severity of symptoms alongside systemic healthcare inequities. This review identifies the inflammatory pathways driving HS, including TNF-alpha, IL-1β, and the IL-17/IL-23 axis, and examines the critical role of dysregulated microRNAs (miRNAs) such as miR-24-1-5p and miR-146a-5p. These miRNAs exacerbate inflammation and contribute to disease progression. The authors highlight the potential of miRNA-based therapies and advanced diagnostic tools like wearable biosensors to transform HS management. The review advocates for targeted, personalized treatments that address the disease's complex genetic and environmental triggers. The study aims to improve outcomes and restore hope for those suffering from this relentless condition by tackling these challenges.
